To get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.
For over 70 years we have been pioneering research methods to help protect people from infections.
Our work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer
Our expertise in oncology allows us to bring groundbreaking cancer therapies to our patients.
We’re focused on unlocking the science of the immune system to understand how the body’s react.
Our current opportunity-driven ares of focus.
Explore our innovation stories
Innovation is at the very core of GSK. Discover how we're uniting science, technology and talent to get ahead of disease together.